比较脑外科临床上采用微创穿刺与小骨孔开颅治疗高血压脑出血的疗效。

对胶州市人民医院脑外科收治76例的高血压脑出血患者临床资料进行回顾性分析，将所有患者随机分成两组，常规组患者采用小骨孔开颅治疗，研究组患者采用微创穿刺治疗，比较两组患者临床治疗效果。

研究组患者术后美国国立卫生研究院卒中量表(以下简称NIHSS)评分为(6.04±0.57)分，(t＝2.54，P>0.05)；常规组患者术后NIHSS评分为(6.01±0.58)分，(t＝1.94，P>0.05)。研究组患者术后3个月格拉斯哥预后评分(简称GOS)为(4.28±0.37)分，常规组为(4.30±0.30)分。研究组患者的住院时间、术后并发症发生率显著短于或低于常规组。研究组患者住院时间为(16.5±2.8)d，常规组为(21.3±4.8)d(χ²＝8.74，P<0.05)；研究组患者临床并发症发生率为2.63%，常规组患者临床并发症发生率为10.52%(χ²＝10.54，P<0.05)。

相较小骨孔开颅采用微创穿刺治疗高血压脑出血患者的疗效更好。

To compare the clinical department of cerebral surgery by minimally invasive puncture and keyhole craniotomy in treatment of hypertensive cerebral hemorrhage patients.

A retrospective analysis was performed on clinical data of 76 cases of hypertensive cerebral hemorrhage admitted into cerebral surgery, People’s Hospital of Jiaozhou City. All patients were randomly divided into two groups, ie, conventional group (treated with small bone hole craniotomy treatment) and study group (treated with minimally invasive treatment). The clinical therapeutic effect was compared in two groups.

In the study group, the stroke scale (NIHSS) score (t=2.54, P>0.05) was (6.04±0.57) points, and the NIHSS score was (6.01±0.58) points (t=1.94, P>0.05). Three months after surgery, the Glasgow outcome score (GOS) in the study group was (4.28±0.37) points, and the normal group was (4.30±0.30) points. The incidence of complications in the study group was significantly lower than that in the control group. The hospitalization time of the study group was (16.5±2.8) days, and the normal group was (21.3±4.8) days (X²=8.74, P<0.05). The clinical complication rate was 2.63% in the study group and 10.52% in the conventional group (χ²=10.54, P<0.05).

Compared with keyhole craniotomy, minimally invasive treatment has better curative effect for patients with hypertensive cerebral hemorrhage.